The purpose of this lecture is to review strategies for evaluating supportive care interventions targeting patients and families, clinicians, and health care delivery systems. We will review three interventions which focused on each of these targets and discuss the successes/failures and pros/cons to each strategy. We will utilize a “lessons learned” approach to educate the audience on the essential tasks and steps to develop, implement and complete a successful supportive care clinical trial.
Participants will present the specific aims for their studies and ideas for the sample. Revised specific aims are due at the beginning of Day 3.
Locations:
Temel: Commonwealth B
Pirl/Safren: Capital B
El-Jawahri: Commonwealth A
Park: Beacon A
Greer: Boardroom
Wood: Capital A
This lecture will detail the steps involved in working with stakeholders in research and how to maximize the benefits of their participation.
Participants will present the flow diagram (schema) of their study design and list what data they plan to collect. A patient or family member stakeholder will participate in each small group to offer their perspectives on recruitment, study procedures, and relevance of the studies to patients and their families. If a participant is proposing a study which is a secondary analysis of previously collected data, plans for identifying the analytic sample will be discussed. This discussion will prepare participants for writing a draft analytic plan for the study, which is due at the beginning of Day 4.
Locations
Temel: Commonwealth B (Wednesday suite 1423 on 14th floor)
Pirl/Safren: Capital B (Wednesday suite 823 on 8th floor)
El-Jawahri: Commonwealth A (Wednesday suite 923 on 9th floor)
Park: Beacon A (Wednesday suite 1123 on 11th floor)
Greer: Boardroom (Wednesday suite 1223 on 12th floor)
Wood: Capital A (Wednesday suite 1023 on 10th floor)
A patient treated for advanced cancer will tell his story and the important role of supportive care in his cancer treatment. He will discuss the importance of supportive oncology research to patients and their families and how to engage them as stakeholders in this research. This talk, which the patient has given before, is meant to inspire participants at this stage of the workshop and to prepare them for working with patient and family stakeholders in their small groups later that day.
1:00-1:45 pm: Poort
1:45-2:30 pm: Loh
2:30-3:15 pm: Stevens
3:15-4:00 pm: Ralston
4:00-4:45 pm: Yusufov
Each participant will have an individual 20-minute meeting with their small group leader.
In this informal session, participants will discuss qualitative research coding and interpretation, with opportunity for hands-on experience reviewing transcript exerpts and developing a coding structure. Specific attention will be drawn to strategies and approaches for suppoting rigor in the analysis process.
Analytic plans often determine sample size. Participants will briefly present their analytic plans and then ideas for recruitment and enrollment and obtain feedback from the group and leader to enable them to complete the sample, recruitment, and enrollment sections of their protocols, which will be due at the beginning of Day 5.
Over the course of the week, questions will be collected on IRB issues. This session will be a Question and Answer with collected questions and discussion with participants.
A selection of workshop faculty will present stories of their early career and challenges.
Discussion will focus on any potential safety issues and plans to reduce risk. Because this is the last small group, participants will have the opportunity to receive help from the group on problems they might have encountered in writing their protocols. Complete protocols are due on Day 6.
